Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
Journal of Clinical Lipidology · 2026-06 · 20 (6) · e76-e77
DOI: 10.1016/j.jacl.2026.05.112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2026-06. Verfasst von Ran Jin und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jin, R., Hurwitz, K., Kent, S., Jackman, L., Dhalwani, N., Accortt, N., Brookhart, M. A., Head, L., Desai, N., & Lai, E. C. C. (2026). Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease. Journal of Clinical Lipidology, 20(6), e76-e77. https://doi.org/10.1016/j.jacl.2026.05.112
Vancouver
Jin R, Hurwitz K, Kent S, Jackman L, Dhalwani N, Accortt N, et al. Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease. Journal of Clinical Lipidology. 2026;20(6):e76-e77. doi:10.1016/j.jacl.2026.05.112
BibTeX
@article{Jin2026,
author = {Jin, Ran and Hurwitz, Kathleen and Kent, Shia and Jackman, Leah and Dhalwani, Nafeesa and Accortt, Neil and Brookhart, M. Alan and Head, Lisa and Desai, Nihar and Lai, Edward Chia Cheng},
title = {Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease},
journal = {Journal of Clinical Lipidology},
year = {2026},
volume = {20},
number = {6},
pages = {e76--e77},
doi = {10.1016/j.jacl.2026.05.112}
}
EUVIMED